相关实验视频
Updated: May 11, 2025

08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
4.3K
成年人X相关低血症的管理:一个国际工作组临床实践指南
Aliya A Khan1, Dalal S Ali1, Natasha M Appelman-Dijkstra2
1Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON L8S 4L8, Canada.
The Journal of clinical endocrinology and metabolism
|April 17, 2025
概括
新的指导方针推布罗苏马布用于成年人X链接低血症 (XLH) 治疗,从而改善骨折愈合. 布罗苏马布比传统治疗更好,特别是在有症状的患者中.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 与X相关的低酸血症 (XLH) 是一种罕见的遗传疾病,其特征是脏酸盐浪费.
- 诊断和管理XLH需要一个多学科的方法和基于证据的策略.
研究的目的:
- 制定全球,基于证据的指导方针,用于诊断,管理和监测X链接低血症 (XLH) 在成年人.
- 根据系统性审查和专家共识,为XLH治疗提供全面的建议.
主要方法:
- 一个国际工作组 (IWG) 对布罗苏马布和常规治疗方法进行了系统和叙述性审查.
- 用GRADE方法来评估治疗结果的证据确定性.
- 根据现有证据制定了建议,包括患者重要的结果.
主要成果:
- XLH诊断整合了临床,实验室 (脏酸盐浪费) 和骨成像发现.
- 布罗苏马布 (布罗苏马布) 治疗可以显著改善成年人XLH骨折和伪骨折的愈合.
- 纤维细胞生长因子23 (FGF23) 的测量和PHEX基因分析有助于诊断.
结论:
- 强烈建议在XLH成年人经历骨折或伪骨折时使用布罗苏马布,而不是没有治疗.
- 布罗苏马布被建议作为一种优选的治疗方法,而不是常规治疗XLH,即使没有骨折.
- 传统疗法仍然是一个选择,如果burosumab是不可用的症状的成年人.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
91
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
91
Chronic Pancreatitis II: Collaborative Care
49
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
49
Protein Kinases and Phosphatases
12.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.9K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
86
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
86
Phosphoinositides and PIPs
7.2K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.2K
Acute Pancreatitis II: Clinical Manifestations and Management
71
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
71

